Tiziana Life Sciences is trading at $0.95 (-5.88%), with broad risk-off sentiment the likeliest explanation for the October 22 decline; no company-specific catalyst was confirmed. - The Nasdaq was down 2.28% and the S&P 500 down 1.38%, amid geopolitical tensions and concerns about AI spending. - The latest company announcement concerned attendance at a Toronto research meeting, not a material business update. - Live trading was reported at 10:53 a.m. ET; volume information was unavailable.